These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36598859)

  • 1. Loss of CDKN2A Cooperates with WWTR1(TAZ)-CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma.
    Seavey CN; Hallett A; Li S; Che K; Pobbati AV; Ma S; Burtscher A; Kanai R; Lamar JM; Rubin BP
    Clin Cancer Res; 2023 Jul; 29(13):2480-2493. PubMed ID: 36598859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma.
    Driskill JH; Zheng Y; Wu BK; Wang L; Cai J; Rakheja D; Dellinger M; Pan D
    Genes Dev; 2021 Apr; 35(7-8):495-511. PubMed ID: 33766984
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Seavey CN; Pobbati AV; Hallett A; Ma S; Reynolds JP; Kanai R; Lamar JM; Rubin BP
    Genes Dev; 2021 Apr; 35(7-8):512-527. PubMed ID: 33766982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.
    Errani C; Zhang L; Sung YS; Hajdu M; Singer S; Maki RG; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2011 Aug; 50(8):644-53. PubMed ID: 21584898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
    Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP
    Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
    Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR
    Elife; 2021 Apr; 10():. PubMed ID: 33913810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogenic fusion protein TAZ::CAMTA1 promotes genomic instability and senescence through hypertranscription.
    Neil E; Paredes R; Pooley O; Rubin B; Kouskoff V
    Commun Biol; 2023 Nov; 6(1):1174. PubMed ID: 37980390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras-MAPK Signaling in Epithelioid Hemangioendothelioma.
    Ma S; Kanai R; Pobbati AV; Li S; Che K; Seavey CN; Hallett A; Burtscher A; Lamar JM; Rubin BP
    Clin Cancer Res; 2022 Jul; 28(14):3116-3126. PubMed ID: 35443056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the Hippo-YAP/TAZ Pathway in Epithelioid Hemangioendothelioma and its Potential as a Therapeutic Target.
    Suto H
    Anticancer Res; 2024 Oct; 44(10):4147-4153. PubMed ID: 39348982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma.
    Seligson ND; Awasthi A; Millis SZ; Turpin BK; Meyer CF; Grand'Maison A; Liebner DA; Hays JL; Chen JL
    JAMA Netw Open; 2019 Oct; 2(10):e1912416. PubMed ID: 31577358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions.
    Anderson T; Zhang L; Hameed M; Rusch V; Travis WD; Antonescu CR
    Am J Surg Pathol; 2015 Jan; 39(1):132-9. PubMed ID: 25353289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma.
    Tanas MR; Sboner A; Oliveira AM; Erickson-Johnson MR; Hespelt J; Hanwright PJ; Flanagan J; Luo Y; Fenwick K; Natrajan R; Mitsopoulos C; Zvelebil M; Hoch BL; Weiss SW; Debiec-Rychter M; Sciot R; West RB; Lazar AJ; Ashworth A; Reis-Filho JS; Lord CJ; Gerstein MB; Rubin MA; Rubin BP
    Sci Transl Med; 2011 Aug; 3(98):98ra82. PubMed ID: 21885404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
    Patel NR; Salim AA; Sayeed H; Sarabia SF; Hollingsworth F; Warren M; Jakacky J; Tanas M; Oliveira AM; Rubin BP; Lazar AJ; López-Terrada D; Wang WL
    Histopathology; 2015 Nov; 67(5):699-708. PubMed ID: 25817592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
    Doyle LA; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary pulmonary epithelioid hemangioendothelioma metastatic to the pleura and mediastinal lymph node with a prominent rhabdoid cytomorphology showing CAMTA1::WWTR1 fusion and novel PRDM1 and TNFRSF14 mutations.
    Gonzalez MF; Seth A
    Cytopathology; 2024 Sep; 35(5):654-657. PubMed ID: 38943251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Large Meningeal Epithelioid Hemangioendothelioma With WWTR1-CAMTA1 Gene Rearrangement and Slow Growth Over 15 Years.
    Süß P; Volz F; Lang C; Staszewksi O; Palmedo G; Taschner CA; Scheiwe C; Kurz P; Mentzel T; Prinz M
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):871-876. PubMed ID: 30085199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein.
    Tanas MR; Ma S; Jadaan FO; Ng CK; Weigelt B; Reis-Filho JS; Rubin BP
    Oncogene; 2016 Feb; 35(7):929-38. PubMed ID: 25961935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpoints.
    Errani C; Sung YS; Zhang L; Healey JH; Antonescu CR
    Cancer Genet; 2012; 205(1-2):12-7. PubMed ID: 22429593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.
    Rosenbaum E; Jadeja B; Xu B; Zhang L; Agaram NP; Travis W; Singer S; Tap WD; Antonescu CR
    Mod Pathol; 2020 Apr; 33(4):591-602. PubMed ID: 31537895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid Hemangioendothelioma.
    Pobbati AV; Burtscher A; Rajaram Siva N; Hallett A; Romigh T; Che K; Zhao B; Coker JA; Wang N; Stauffer SR; Rubin BP
    Clin Cancer Res; 2024 Sep; 30(18):4179-4189. PubMed ID: 39052240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.